Abstract：
Hepatic hemangioma, focal nodular hyperplasia, and hepatic adenoma are the most common benign solid liver tumors. However, their surgical indications have been the subject of debate. Minimally invasive liver resection reduces the cost of surgery and may lead to overtreatment of benign liver tumors. Recently, there has been a growing understanding of the etiology, pathogenesis, and natural history of these tumors. Great progress has also been made in imaging. The use of MRI and contrast agents has improved the accuracy of non-invasive diagnosis of these tumors, and especially in the identification of specific molecular subtypes of liver adenoma. These factors have resulted in alterations of surgical indications for these tumors. This article examines recent literature and it discusses the surgical indications for hepatic hemangioma, focal nodular hyperplasia, and hepatic adenoma while summarizing modifications in clinical management.
摘要：
肝血管瘤，局灶性结节增生,肝腺瘤是最常见的良性实体肝肿瘤。然而,他们的手术适应症一直是争论的话题。微创肝切除术可降低手术成本，并可能导致良性肝肿瘤的过度治疗。最近,对病因的了解越来越多，发病机制，和这些肿瘤的自然史。在成像方面也取得了很大进展。MRI和造影剂的使用提高了这些肿瘤的非侵入性诊断的准确性，特别是在鉴定肝腺瘤的特定分子亚型方面。这些因素导致了这些肿瘤的手术适应症的改变。本文研究了最近的文献，并讨论了肝血管瘤的手术指征，局灶性结节增生,和肝腺瘤，同时总结临床管理的修改。
